RinGlar®

DRUG2 trials

Sponsors

Geropharm

Conditions

Clamp StudyType 1 Diabetes Mellitis

Phase 3

Evaluation of Insulin Glulisine (GP40321) Compared to Insulin Glulisine (Apidra® SoloStar®) in Type 1 Diabetes Mellitus Patients

CompletedNCT07070752

GeropharmType 1 Diabetes Mellitis

Start: 2023-04-14End: 2023-11-28Updated: 2025-07-22

Unknown Phase

A Study to Compare Pharmacokinetics and Pharmacodynamics of RinGlar® to Lantus® in Type 1 Diabetes Mellitus Patients

CompletedNCT04101383

GeropharmClamp Study

Start: 2017-10-16End: 2018-02-16Updated: 2019-09-24

Related Papers

Immunogenicity, efficacy and safety of a biosimilar insulin glulisine compared with originator in adults with type 1 diabetes mellitus: A phase III randomised clinical trial.

2025-12-09